Passersby walk in front of video monitors announcing the Carlyle Group’s listing on the NASDAQ market site in New York’s Times Square after the opening bell for trading, U.S. May 3, 2012. REUTERS/Keith Bedford/File Photo
June 27, 2020
(Reuters) – U.S.-based Carlyle Group Inc has agreed to buy a 20% stake in India’s Piramal Enterprises Ltd’s pharmaceutical businesses for about $490 million, the companies said in a statement on Saturday.
The capital increase aims to accelerate Piramal Pharma’s organic and inorganic growth plans, according to the statement.
(Reporting by Maria Ponnezhath in Bengaluru; Editing by William Mallard)
